Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.05.23
海普瑞：关于选举职工代表监事的公告
2023.05.23
海普瑞：关于聘任董事会秘书和证券事务代表的公告
2023.05.23
海普瑞：第六届监事会第一次会议决议公告
2023.05.23
海普瑞：第六届董事会第一次会议决议公告
2023.05.23
海普瑞：2022年年度股东大会决议公告
2023.05.23
海普瑞：2022年年度股东大会法律意见书
2023.04.12
海普瑞：关于举行2022年度网上业绩说明会的公告
2023.04.04
海普瑞：关于子公司签订分销供应协议的公告
2023.03.30
海普瑞：年度股东大会通知
2023.03.30
海普瑞：内部控制自我评价报告
第一页
上一页
4
5
6
7
8
下一页
最后一页
